Supplementary_Material – Supplemental material for Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

E. Lacy, Brian; Harris, Lucinda A.; Chang, Lin; Lucak, Susan; Gutman, Catherine; Dove, Leonard S.; Covington, Paul S.; Lembo, Anthony

doi:10.25384/SAGE.7998686.v1

Supplementary_Material.pdf (134.32 kB)

Supplementary_Material – Supplemental material for Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

journal contribution

posted on 2019-04-15, 12:00 authored by Brian E. Lacy, Lucinda A. Harris, Lin Chang, Susan Lucak, Catherine Gutman, Leonard S. Dove, Paul S. Covington, Anthony Lembo

Supplemental material, Supplementary_Material for Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials by Brian E. Lacy, Lucinda A. Harris, Lin Chang, Susan Lucak, Catherine Gutman, Leonard S. Dove, Paul S. Covington and Anthony Lembo in Therapeutic Advances in Gastroenterology